Proliferation of CECs requires dual signaling through both MAPK/ERK and PI 3-K/Akt pathways

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 2, 2001, Pages 488-496

  Zubilewicz, A ^a   Hecquet, C ^a   Jeanny, J C ^a   Soubrane, G ^a   Courtois, Y ^a   Mascarelli, F ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BRAIN EXTRACT; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN ANTIBODY;

ANIMAL CELL; ARTICLE; CATTLE; CELL CULTURE; CELL PROLIFERATION; CHOROID; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; CATTLE; CELL DIVISION; CELLS, CULTURED; CHOROID; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 0035146349     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. The choroid: Structural consideration
2. Angiogenic factors
3. New vessel function beneath the retinal pigment epithelium in senile eye
4. Choroidal neovascularisation
5. Subretinal neovascularisation: Natural history of an experimental model
6. Choroidal neovascularisation and the retinal pigment epithelium
7. MMP inhibitor: Experimental and clinical studies
8. Rapid isolation of choriocapillary endothelial cells by Lycopersicin esculentum-coated Dynabeads
9. The ins and outs of kinases
10. Signaling by dual specificity kinases
11. Cell cycle target of Ras/Raf signaling
12. Role of PI 3-K in activation of Ras and MAP kinase by epidermal growth factor
13. Structure and function of phosphoinositide 3-kinase
14. PKB/Akt connecting PI 3-kinase to cell survival and beyond
15. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity
16. Endogenous FGF1-induced activation and synthesis of ERK2 reduce cell apoptosis in RPE cells
17. Regulation of FGF soluble receptor type 1 (SR1) expression and distribution in developing, degenerating and FGF2-treated retina
18. Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway
19. Utilization ot distinct signaling pathways by receptors for VEGF and others mitogens in the induction of endothelial cell proliferation
20. Paracrine effects of phosphorylated and excreted FGF1 by retinal pigmented epithelial cells
21. Activation of the MAP kinase/ERK pathway by conventional novel and atypical protein kinase C isotype
22. Activation of MAP kinase is necessary and sufficient for PC 12 differentiation and for transformation of NIH 3T3 cells
23. Both FGF1 and Bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: Rôle of the extracellular signal-regulated kinase 2
24. Identification of regulatory phosphorylation site in MAP kinase-activated kinase p90RSK that are inducible by MAP K
25. NO and NAC inhibit the activation of MAP K by angiotensin II in rat cardiac fibroblast
26. Agonist-stimulated synthesis of PI 3 Phosphate: A new intracellular signaling system
27. Mechanism of activation of protein kinase by insulin and IGF1
28. PI 3-K signals activation of p70 S6 kinase in situ through site of specific p70 S6 kinase phosphorylation
29. A mammalian protein target by G1-arresting rapamycin-receptor complex
30. The ERK pathway contributes to mitogenic and anti apoptotic effects of peroxisome proliferators in vitro
31. Sensitization of HL 60 human leukemic cells to cytotoxic drug-induced apoptosis by inhibition of PI 3-K survival signals
32. Increasing complexity of Ras signaling
33. Cell cycle targets of Ras/Raf signalling
34. Nerve growth factor regulates the expression and activity of p33 cdk2 and p 34 cdc2 kinases in PC12 cells
35. Neuronal differentiation is associated with prolonged p21 ras activity and consequent prolonged ERK activity
36. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupt morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells
37. Induction of apoptotic cell death in vascular endothelial cells cultured in three-dimensional collagen lattice
38. Signal transduction protein ERK1 and 2 are therapeutic target of the inhibitors of retinal angiogenesis
39. Mechanism of hepatocyte growth factor-induced retinal endothelial cell migration and growth
40. Sustained activation of the mitogen-activated protein kinase pathway: A mechanism underlying receptor tyrosine kinase. Specificity for matrix metalloproteinase-9 induction and cell migration
41. Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1
42. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes
43. ERK/JNK cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation
44. Roles of ERK1/2 and p38 mitogenactivated protein kinase in the signaling transduction of basic FGF in endothelial cells during angiogenesis
45. Roles of PI 3-K and MAPK pathways in stimulation of vascular smooth muscle cell migration and deoxyribonucleic acid synthesis by insulin-like growth factor 1
46. p70S6 K function is essential for G1 progression
47. p70S6K-mediated protein synthesis is a critical step for vascular endothelial cell proliferation
48. MAP kinase, PI 3-K a,d p70 S6K mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor
49. Interactive roles of Ras, insulin receptor substrate 1 and proteins with src homology 2 domain in insulin signaling in Xenopus oocytes
50. Ras dependent induction of cellular responses by constitutively active PI 3-K
51. PI 3-K is not required for activation of MAPK by cytokines
52. Wortmannin inhibits MAP kinase activation by platelet activator factor through a mechanism independent of p85/p11O-type PI 3-kinase
53. Conditional inhibition of the MAP kinase cascade by wortmannin